Market Tracker

05/27 5:16pm ET

Trovagene Inc (NASDAQ:TROV)

11.19
Delayed Data
As of 4:00pm ET
 +0.23 / +2.10%
Today’s Change
2.97
Today|||52-Week Range
11.68
+160.23%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close10.96
Today’s open11.02
Day’s range11.01 - 11.50
Volume621,019
Average volume (3 months)415,619
Market cap$268.0M
Dividend yield--
Data as of 4:00pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-26.32%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales290.13
Price/Book24.83

Competitors

 Today’s
change
Today’s
% change
TTHITransition Therapeut...+0.34+4.62%
VCYTVeracyte Inc0.000.00%
QTNTQuotient Ltd-0.09-0.61%
OXFDOxford Immunotec Glo...-0.33-2.44%
Data as of 4:00pm ET, 05/27/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts